gla-lsq
Small moleculeexperimental
Clinical trial activity
2 trials · 12 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2016 (NCT02647489)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Toll-like receptor 4AGONIST
TLR4 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gla-lsq
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04177355 | Phase 1 | Dec 18, 2019 | Dynavax Technologies Corporation, Emory University, HIV Vaccine Trials Network, Infectious Disease Research Institute, International AIDS Vaccine Initiative, National Institute of Allergy and Infectious Diseases (NIAID), University of Washington |
| NCT02647489 | Phase 1 | May 1, 2016 | European Malaria Vaccine Initiative, Expres2ion Biotechnologies APS, Government of France, University of Copenhagen, University of Tuebingen |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (12)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dynavax Technologies Corporation | For profit | 1 | 0 | 1 | 2019 |
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| European Malaria Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Expres2ion Biotechnologies APS | For profit | 1 | 0 | 1 | 2016 |
| Government of France | Government | 1 | 0 | 1 | 2016 |
| HIV Vaccine Trials Network | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Infectious Disease Research Institute | Academic/Hospital | 1 | 0 | 1 | 2019 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2019 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2019 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Tuebingen | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2019 |
12 organizations
Page 1 / 1